Protective effects of gabapentin on allodynia and α2δ1-subunit of voltage-dependent calcium channel in spinal nerve-ligated rats

Journal of Korean Medical Science

Volumn 24, Issue 1, 2009, Pages 146-151

  Hahm, Tae Soo ^a   Ahn, Hyun Joo ^a   Bae, Chang Dae ^b   Kim, Han Seop ^b   Lim, Seung Woon ^c   Cho, Hyun Sung ^a   Lee, Sangmin M ^a   Sim, Woo Seog ^a   Kim, Jie Ae ^a   Gwak, Mi Sook ^a   Choi, Soo Joo ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Chungbuk National University College of Medicine   (South Korea)

Author keywords

Alpha 2 delta 1 subunit; Calcium channels; Gabapentin; Neuropathic pain; Protective

Indexed keywords

4 AMINOBUTYRIC ACID; ALPHA2DELTA 1 PROTEIN, RAT; ALPHA2DELTA-1 PROTEIN, RAT; AMINE; ANALGESIC AGENT; CALCIUM CHANNEL; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; GABAPENTIN; PROTEIN SUBUNIT;

ANIMAL; ARTICLE; DISEASE MODEL; GENETICS; INTRAPERITONEAL DRUG ADMINISTRATION; LIGATION; MALE; METABOLISM; NEURALGIA; PAIN ASSESSMENT; RAT; SPINAL NERVE; SPRAGUE DAWLEY RAT; UPREGULATION;

AMINES; ANALGESICS; ANIMALS; CALCIUM CHANNELS; CYCLOHEXANECARBOXYLIC ACIDS; DISEASE MODELS, ANIMAL; GAMMA-AMINOBUTYRIC ACID; INJECTIONS, INTRAPERITONEAL; LIGATION; MALE; NEURALGIA; PAIN MEASUREMENT; PROTEIN SUBUNITS; RATS; RATS, SPRAGUE-DAWLEY; SPINAL NERVES; UP-REGULATION;

EID: 65649126704     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2009.24.1.146     Document Type: Article

References (34)

1. Dahl JB, Moiniche S. Pre-emptive analgesia. Br Med Bull 2004; 71: 13-27.
2. Bromley L. Pre-emptive analgesia and protective premedication. What is the difference? Biomed Pharmacother 2006; 60: 336-40.
3. Gee NS, Brown JP, Dissanayake VU, Offord J, Thurlow R, Woodruff GN. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J Biol Chem 1996; 271: 5768-76.
4. Marais E, Klugbauer N, Hofmann F. Calcium channel alpha(2)delta subunits-structure and Gabapentin binding. Mol Pharmacol 2001; 59: 1243-8.
5. Cheng JK, Chen CC, Yang JR, Chiou LC. The antiallodynic action target of intrathecal gabapentin: Ca2+ channels, KATP channels or N-methyl-d-aspartic acid receptors? Anesth Analg 2006; 102: 182-7.
6. Luo ZD, Chaplan SR, Higuera ES, Sorkin LS, Stauderman KA, Williams ME, Yaksh TL. Upregulation of dorsal root ganglion (alpha)2 (delta) calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats. J Neurosci 2001; 21: 1868-75.
7. Luo ZD, Calcutt NA, Higuera ES, Valder CR, Song YH, Svensson CI, Myers RR. Injury type-specific calcium channel alpha 2 delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. J Pharmacol Exp Ther 2002; 303: 1199-205.
8. Li CY, Song YH, Higuera ES, Luo ZD. Spinal dorsal horn calcium channel alpha2delta-1 subunit upregulation contributes to peripheral nerve injury-induced tactile allodynia. J Neurosci 2004; 24: 8494-9.
9. Xiao W, Boroujerdi A, Bennett GJ, Luo ZD. Chemotherapy-evoked painful peripheral neuropathy: analgesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunit. Neuroscience 2007; 144: 714-20.
10. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983; 16: 109-10.
11. Kim SH, Chung JM. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992; 50: 355-63.
12. LaBuda CJ, Little PJ. Pharmacological evaluation of the selective spinal nerve ligation model of neuropathic pain in the rat. J Neurosci Methods 2005; 144: 175-81.
13. Hunter JC, Gogas KR, Hedley LR, Jacobson LO, Kassotakis L, Thompson J, Fontana DJ. The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur J Pharmacol 1997; 324: 153-60.
14. Field MJ, Hughes J, Singh L. Further evidence for the role of the alpha(2)delta subunit of voltage dependent calcium channels in models of neuropathic pain. Br J Pharmacol 2000; 131: 282-6.
15. Back SK, Won SY, Hong SK, Na HS. Gabapentin relieves mechanical, warm and cold allodynia in a rat model of peripheral neuropathy. Neurosci Lett 2004; 368: 341-4.
16. Dixon WJ. Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 1980; 20: 441-62.
17. Chaplan SR, Pogrel JW, Yaksh TL. Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia. J Pharmacol Exp Ther 1994; 269: 1117-23.
18. Rorarius MG, Mennander S, Suominen P, Rintala S, Puura A, Pirhonen R, Salmelin R, Haanpaa M, Kujansuu E, Yli-Hankala A. Gabapentin for the prevention of postoperative pain after vaginal hysterectomy. Pain 2004; 110: 175-81.
19. Kaneko M, Mestre C, Sanchez EH, Hammond DL. Intrathecally administered gabapentin inhibits formalin-evoked nociception and the expression of Fos-like immunoreactivity in the spinal cord of the rat. J Pharmacol Exp Ther 2000; 292: 743-51.
20. Coderre TJ, Kumar N, Lefebvre CD, Yu JS. Evidence that gabapentin reduces neuropathic pain by inhibiting the spinal release of glutamate. J Neurochem 2005; 94: 1131-9.
21. Wallin J, Cui JG, Yakhnitsa V, Schechtmann G, Meyerson BA, Linderoth B. Gabapentin and pregabalin suppress tactile allodynia and potentiate spinal cord stimulation in a model of neuropathy. Eur J Pain 2002; 6: 261-72.
22. Maneuf YP, Hughes J, McKnight AT. Gabapentin inhibits the substance P-facilitated K(+)-evoked release of [(3)H]glutamate from rat caudial trigeminal nucleus slices. Pain 2001; 93: 191-6.
23. Hara K, Sata T. Inhibitory effect of gabapentin on N-methyl-d-aspartate receptors expressed in Xenopus oocytes. Acta Anaesthesiol Scand 2007; 51: 122-8.
24. Ng GY, Bertrand S, Sullivan R, Ethier N, Wang J, Yergey J, Belley M, Trimble L, Bateman K, Alder L, Smith A, McKernan R, Metters K, O'Neill GP, Lacaille JC, Hebert TE. Gamma-aminobutyric acid type B receptors with specific heterodimer composition and postsynaptic actions in hippocampal neurons are targets of anticonvulsant gabapentin action. Mol Pharmacol 2001; 59: 144-52.
25. Nemeroff CB. The role of GABA in the pathophysiology and treatment of anxiety disorders. Psychopharmacol Bull 2003; 37: 133-46.
26. Dooley DJ, Donovan CM, Pugsley TA. Stimulus-dependent modulation of [(3)H]norepinephrine release from rat neocortical slices by gabapentin and pregabalin. J Pharmacol Exp Ther 2000; 295: 1086-93.
27. Freiman TM, Kukolja J, Heinemeyer J, Eckhardt K, Aranda H, Rominger A, Dooley DJ, Zentner J, Feuerstein TJ. Modulation of K+-evoked [3H]-noradrenaline release from rat and human brain slices by gabapentin: involvement of KATP channels. Naunyn Schmiedebergs Arch Pharmacol 2001; 363: 537-42.
28. Mixcoatl-Zecuatl T, Medina-Santillan R, Reyes-Garcia G, Vidal-Cantu GC, Granados-Soto V. Effect of K+ channel modulators on the antiallodynic effect of gabapentin. Eur J Pharmacol 2004; 484: 201-8.
29. Wilson JA, Garry EM, Anderson HA, Rosie R, Colvin LA, Mitchell R, Fleetwood-Walker SM. NMDA receptor antagonist treatment at the time of nerve injury prevents injury-induced changes in spinal NR1 and NR2B subunit expression and increases the sensitivity of residual pain behaviours to subsequently administered NMDA receptor antagonists. Pain 2005; 117: 421-32.
30. Visser E, Schug SA. The role of ketamine in pain management. Biomed Pharmacother 2006; 60: 341-8.
31. Isom LL, De Jongh KS, Catterall WA. Auxiliary subunits of voltage-gated ion channels. Neuron 1994; 12: 1183-94.
32. Gurnett CA, De Waard M, Campbell KP. Dual function of the voltage-dependent Ca2+ channel alpha 2 delta subunit in current stimulation and subunit interaction. Neuron 1996; 16: 431-40.
33. Bolay H, Moskowitz MA. Mechanisms of pain modulation in chronic syndromes. Neurology 2002; 59 (5 Suppl 2): S2-7.
34. Xie W, Strong JA, Meij JT, Zhang JM, Yu L. Neuropathic pain: early spontaneous afferent activity is the trigger. Pain 2005; 116: 243-56.